Latest Articles

Publication Date
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Gynaecology patients going private to escape NHS waiting lists - BBC.com

Gynaecology patients going private to escape NHS waiting lists BBC.com

Published: Dec. 9, 2024, 4:36 p.m.
Gynaecology patients going private to avoid NHS waiting lists - BBC.com

Gynaecology patients going private to avoid NHS waiting lists BBC.com

Published: Dec. 9, 2024, 1:35 p.m.
Patients Take Matters Into Their Own Hands Amid NHS Delays - Evrim Ağacı

Patients Take Matters Into Their Own Hands Amid NHS Delays Evrim Ağacı

Published: Dec. 9, 2024, 10:33 a.m.
Florida Cancer Specialists & Research Institute Case Study Demonstrates Value of Genomic Testing To Improve Treatment and Outcomes For Patients With Inherited Cancers - The Malaysian Reserve

Florida Cancer Specialists & Research Institute Case Study Demonstrates Value of Genomic Testing To Improve Treatment and Outcomes For Patients With Inherited Cancers The Malaysian Reserve

Published: Dec. 6, 2024, 4:44 p.m.
What doctors wish patients knew about endometriosis - American Medical Association

What doctors wish patients knew about endometriosis American Medical Association

Published: Dec. 6, 2024, 1 p.m.
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer BioSpace

Published: Dec. 6, 2024, 8:22 a.m.
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.
Rare Disorder Makes Patients Scream In Pain While Vomiting, Causes Teeth Loss: Cannabis-Linked Syndrome On Rise - Medical Daily

Rare Disorder Makes Patients Scream In Pain While Vomiting, Causes Teeth Loss: Cannabis-Linked Syndrome On Rise Medical Daily

Published: Dec. 4, 2024, 5:51 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!